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Figure. Pathological findings of a 33-year-old male who underwent a craniotomy for resection of a WHO grade 2 
frontal lobe oligodendroglioma; A - Coronal section of the encephalic frontal lobe showing a poorly defined reddish 
smooth mass in the cortex and white matter, with enlargement of the affected area, especially the superior frontal 
gyrus on the left hemisphere; B - Photomicrography of the central nervous system tumor depicting a diffusely infiltrating 
glioma composed of monomorphic cells with uniform round vesicular nuclei, distinct small nucleoli, and perinuclear 
halo (“fried egg appearance”); C - Gross examination of the prostate gland and surrounding tissue with extensive 
recent periprostatic venous thromboses; D - Gross examination of the lung showing a wedge-shaped, hemorrhagic 
area, based on the pleura, which corresponds to a recent pulmonary infarct due to a pulmonary embolism.
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Oligodendroglial tumors account for less than 
10% of diffuse type gliomas, which are graded from 
low to high according to the WHO 2015 classification.1 
Patients harboring brain tumors — especially those 
with high-grade gliomas (HGG) — have a higher risk of 
developing venous thromboembolism (VTE), including 
deep venous thrombosis (DVT) and/or pulmonary 
embolism (PE).2,3 Local synthesis of the tissue factor 
(TF), along with many other factors, is related to an 
increased VTE rate in these patients, especially those 
who have undergone cranial neurosurgical procedures 
— particularly a biopsy or a subtotal resection. 
The combination of a neurosurgical intervention 
and a remnant tumor constitute a higher risk for 
thromboembolic events.3 In a previous study,3 among 
63 HGG patients who were followed over a median 
period of 348 days, 15 (24%) presented VTE; 6 (40%) 
had DVT, which was located in the lower extremity in 
five of them; and 9 (60%) had PE (three in combination 
with DVT).
TF,4–7 a potent procoagulant factor whose 
synthesis is up-regulated in a variety of neoplasms 
(including HGG), might play an important role in 
the VTE pathogenesis. TF acts as a high-affinity 
receptor/co-activator for the coagulation factor VII/VIIa 
and triggers the coagulation cascade. A complex 
TF/VIIa formation activates factor X and leads to the 
generation of thrombin, which catalyzes the formation 
of fibrin and the activation of platelets, resulting in 
vascular occlusion and ischemia as well as inflammation 
and angiogenesis. In glioma cells, the amount of TF 
expression correlates with the histological grade.
Tumor dormancy is influenced by TF.4,7 Thus, 
indolent human glioma cells deficient for TF remain 
viable in cell cultures, but are permanently dormant 
for nearly a year when they are injected at a specific 
site, while the expression of TF leads to a stepwise 
transition to latent and overt tumor growth phases — a 
process preceded by the recruitment of vascular cells 
(CD105+) and myeloid (CD11b+ and F4/80+) cells. 
Importantly, the microenvironment orchestrated by TF 
expression drives permanent changes in the phenotype 
gene expression profile, the DNA copy number, 
and the DNA methylation state of tumor cells that 
escaped from dormancy. Some authors postulate that 
procoagulant events in the tissue microenvironment 
(niche) may affect the fate of occult tumor cells, 
including biological and genetic progression to initiate 
full-blown malignancy.4
Periprostatic or paravaginal areas are rarely 
considered to be sites of clot origin in patients with 
PE.8,9 The majority of emboli have been demonstrated 
to originate in the veins of the legs. As far as we know, 
the first reported case of PE as a result of thrombosis 
from the periprostatic venous plexus in a young patient 
with a normal prostate gland and no history of prostate 
trauma was published in 2003.8 Three other cases were 
described three years later.9
In 1819, Gilbert Breschet provided the first 
detailed anatomic description of the vertebral venous 
plexus (VVP). It was described as a large plexiform 
valveless network of vertebral veins consisting of 
three interconnecting divisions and spanning the 
entire spinal column with connections to the cranial 
dural sinuses, which were distributed in a longitudinal 
pattern and ran parallel to the venae cavae with which 
they communicated, with multiple interconnections.10
In 1940, Oscar V. Batson reported the true 
functionality of the VVP by proving the continuity 
of the prostatic venous plexus with the VVP and 
proposed this route as the most plausible explanation 
for the distribution of prostate metastatic disease. 
With his seminal work, Batson reclassified the human 
venous system to consist of caval, pulmonary, portal, 
and vertebral divisions. Further advances in imaging 
technology confirmed Batson’s results. Today, the VVP 
is considered part of the cerebrospinal venous system, 
which is regarded as a unique, large-capacitance, 
valveless plexiform venous network in which flow is 
bidirectional. This system plays an important role in 
the regulation of intracranial pressure with changes in 
posture and venous outflow from the brain; whereas, 
in disease states, it provides a potential route for the 
spread of tumors, infections, or emboli.10
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